HKU Scholars Hub: Browsing DSpace

Browsing by Author Wong, WLD

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 8 to 21 of 21 < previous

	Title	Author(s)	Issue Date	Views
	Human Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Prevent Adriamycin Nephropathy in Mice Journal:Oncotarget	Wu, H Yiu, WH Wong, WLD Li, RX Chan, YY Leung, JCK Zhang, Y Lian, Q Lai, KN Tang, SCW Tse, HF	2017	72
	Inhibition of miR-34a reduces podocyte apoptosis by targeting Bcl-2 and autophagy Proceeding/Conference:Journal of the American Society of Nephrology	Liu, Y Li, R Yiu, WH Wu, H Wong, WLD Leung, JCK Chan, LY Lai, KN Saleem, M Mathieson, PW Tang, SCW	2015	89
	Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-induced oxidative stress Journal:Kidney International	Yiu, WH Wong, WLD Wu, H Li, R Yam, IYL Chan, YY Leung, JCK Lan, HY Lai, KN Tang, SCW	2016	145
	Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-Induced oxidative stress Proceeding/Conference:Journal of the American Society of Nephrology	Yiu, WH Wong, WLD Wu, H Li, R Chan, LYY Leung, JCK Lan, HY Lai, KN Tang, SCW	2015	92
	N-Acetyl-seryl-aspartyl-lysyl-proline Alleviates Renal Fibrosis Induced by Unilateral Ureteric Obstruction in BALB/C Mice Journal:Mediators of Inflammation	Chan, GCW Yiu, WH Wu, H Wong, WLD Lin, M Huang, XR Lan, HY Tang, SCW	2015	84
	Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy – Interim analysis of an add-on, randomised, controlled, multi-centre, open-label pragmatic trial Proceeding/Conference:International Congress of Chinese nephrologists	Chan, KW Kwong, ASK Lui, SL Ip, TP Chan, GCW Cowling, BJ Yiu, WH Wong, WLD LI, B LI, Y Feng, Y Tan, KCB Chan, YY Leung, JCK Lai, KN Tang, SCW	2017	49
	Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy – Preliminary results of an add-on, randomised, controlled, multi-centre, open-label pragmatic trial Proceeding/Conference:Journal of the American Society of Nephrology	Chan, KW Kwong, ASK Lui, SL Ip, TP Chan, GCW Cowling, BJ Yiu, WH Wong, WLD Li, B Li, Y Feng, Y Tan, KCB Chan, YY Leung, JCK Lai, KN Tang, SCW	2017	33
	Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy: Interim analysis of an add-on, randomised, controlled, multi-centre, open-label pragmatic trial Proceeding/Conference:Hong Kong Medical Journal	Chan, KW Kwong, ASK Lui, SL Ip, TP Chan, GCW Cowling, BJ Yiu, WH Wong, WLD Li, B Li, Y Feng, Y Tan, KCB Chan, YY Leung, JCK Lai, KN Tang, SCW	2018	34
	Semi-individualised Chinese Medicine Treatment for Diabetic Kidney Disease – From users’ perspectives to SCHEMATIC trial interim result and potential mechanisms Proceeding/Conference:Advances in Integrative Medicine	Chan, KW Kwong, ASK Chan, GCW Leung, CPS Yiu, WH Lui, SL Ip, TP Cowling, BJ Wong, WLD Li, B Li, Y Feng, Y Chan, YY Leung, JCK Tan, KCB Wong, CWV Lai, KN Tang, SCW	2019	65
	Spleen Tyrosine Kinase Inhibitor Ameliorates Tubular Inflammation in IgA Nephropathy. Proceeding/Conference:Journal of the American Society of Nephrology	Yiu, WH Wong, WLD Wu, H Chan, KW Liu, Y Chan, LYY Leung, JCK Lai, KN Tang, SCW	2016	37
	The Expectation, Concern, and Experience of patients towards Integrative Chinese-western Medicine for Diabetic Kidney Disease: A qualitative study Proceeding/Conference:Journal of the American Society of Nephrology	Chan, KW Leung, C Chan, GCW Yiu, WH Wong, WLD Li, B Li, Y Chan, YY Leung, JCK Tang, SCW	2017	22
	Thrombin induces Epithelial-Mesenchymal Transition through the activation of PAR-1 in Tubular Epithelial Cells Proceeding/Conference:Journal of the American Society of Nephrology	Yiu, WH Wong, WLD Leung, JCK Chan, LYY Lai, KN Tang, SCW	2014	79
	Tissue kallikrein mediates pro-inflammatory pathways and activation of protease-activated receptor-4 in proximal tubular epithelial cells. Journal:PLoS ONE	Yiu, WH WONG, WLD Chan, YY Leung, JCK Chan, KW lan, HY Lai, KN Tang, SCW	2014	88
	The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy Journal:Kidney International	Lin, MIAO Yiu, WH LI, R WU, H WONG, WLD Chan, YY Leung, JCK Lai, KN Tang, SCW	2013	77

Showing results 8 to 21 of 21 < previous